Compound Report Overview
Compound Name:
TRETINOIN
Compound Identifier:
602252
Mol Structure 2D:
602252
Molecular Weight:
300
Formula:
C20 H28 O2
Development Status:
US FDA Approved
SMILES:
CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| TRETINOIN | 631 | Protein Serine/Threonine Kinase, ERK2 | View |
| TRETINOIN | 205 | Serotonin 5-HT2B | View |
| TRETINOIN | 634 | Protein Tyrosine Kinase, EGF Receptor | View |
| TRETINOIN | 632 | Protein Serine/Threonine Kinase, p38alpha | View |
| TRETINOIN | 85 | Adrenergic alpha2B | View |
| TRETINOIN | 216 | Sodium Channel, Site 2 | View |
| TRETINOIN | 90 | Adrenergic beta3 | View |
| TRETINOIN | 88 | Adrenergic beta1 | View |
| TRETINOIN | 208 | Serotonin 5-HT4 | View |
| TRETINOIN | 81 | Adrenergic alpha1B | View |
| TRETINOIN | 8 | ATPase, Na+/K+ | View |
| TRETINOIN | 181 | Opiate delta | View |
| TRETINOIN | 151 | Imidazoline I2, Central | View |
| TRETINOIN | 625 | GABAA, Chloride Channel, TBOB | View |
| TRETINOIN | 619 | Adenosine A3 | View |
| TRETINOIN | 113 | Dopamine D1 | View |
| TRETINOIN | 116 | Dopamine D3 | View |
| TRETINOIN | 76 | Adenosine A2A | View |
| TRETINOIN | 137 | Glucocorticoid | View |
| TRETINOIN | 214 | Sigma2 | View |
| TRETINOIN | 177 | Neuropeptide Y1 | View |
| TRETINOIN | 162 | Leukotriene B4 | View |
| TRETINOIN | 92 | Adrenergic, Norepinephrine Transporter | View |